热敏灸治疗脑卒中后手部痉挛的临床观察

注册号:

Registration number:

ITMCTR2100005114

最近更新日期:

Date of Last Refreshed on:

2021-08-01

注册时间:

Date of Registration:

2021-08-01

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

热敏灸治疗脑卒中后手部痉挛的临床观察

Public title:

Clinical Observation of Heat Sensitive Moxibustion in Treating Hand Spasm after Cerebral Apoplexy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

热敏灸治疗脑卒中后手部痉挛的临床观察

Scientific title:

Clinical Observation of Heat Sensitive Moxibustion in Treating Hand Spasm after Cerebral Apoplexy

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2100049385 ; ChiMCTR2100005114

申请注册联系人:

王慧灵

研究负责人:

王慧灵

Applicant:

Wang Huiling

Study leader:

Wang Huiling

申请注册联系人电话:

Applicant telephone:

+86 15136194032

研究负责人电话:

Study leader's telephone:

+86 15136194032

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

593834521@qq.com

研究负责人电子邮件:

Study leader's E-mail:

593834521@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

河南省郑州市金水区人民路19号

研究负责人通讯地址:

河南省郑州市金水区人民路19号

Applicant address:

19 Renmin Road, Jinshui District, Zhengzhou, He'nan

Study leader's address:

19 Renmin Road, Jinshui District, Zhengzhou, He'nan

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

河南中医药大学第一附属医院

Applicant's institution:

The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2020HL-111-02

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

河南中医药大学第一附属医院伦理委员会

Name of the ethic committee:

Ethics Committee of the First Affiliated Hospital of He'nan University of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020/11/20 0:00:00

伦理委员会联系人:

王春芳

Contact Name of the ethic committee:

Wang Chunfang

伦理委员会联系地址:

河南省郑州市金水区人民路19号

Contact Address of the ethic committee:

19 Renmin Road, Jinshui District, Zhengzhou, He'nan

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 371 66285929

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

河南中医药大学第一附属医院

Primary sponsor:

The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

河南省郑州市金水区人民路19号

Primary sponsor's address:

19 Renmin Road, Jinshui District, Zhengzhou, He'nan

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河南

市(区县):

郑州

Country:

China

Province:

He'nan

City:

Zhengzhou

单位(医院):

河南中医药大学第一附属医院

具体地址:

金水区人民路19号

Institution
hospital:

The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine

Address:

19 Renmin Road, Jinshui District

经费或物资来源:

财政经费

Source(s) of funding:

Financial expenditure

研究疾病:

脑卒中后手部痉挛

研究疾病代码:

Target disease:

Hand cramps after stroke

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

I期临床试验

Phase I clinical trial

研究目的:

1.通过系统化、规范化研究热敏灸法治疗脑卒中后手部痉挛的临床疗效;证实热敏灸是一种安全、有效的改善脑卒中后手部痉挛,提高患者的手功能和生活自理能力的特色疗法。 2.为临床治疗脑卒中后手部痉挛提供了新的思路,同时也为临床提供有效的试验支撑和理论依据,以便推广。

Objectives of Study:

1.Through systematic and standardized research on the clinical efficacy of heat-sensitive moxibustion in the treatment of hand spasm after stroke; it is confirmed that heat-sensitive moxibustion is a safe and effective way to improve hand spasm after stroke and improve the hand function and life of patients Characteristic therapy for self-care ability. 2.It provides new ideas for clinical treatment of post-stroke hand spasm, and at the same time provides effective experimental support and theoretical basis for clinical promotion.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

1.西医诊断标准参照2010年《中国脑血管病防治指南》中“脑卒中”的诊断标准,并均经过 CT 或 MRI 检查确诊为脑血管病; 2.中医诊断标准参照1996年1月国家中医药管理局脑病急症协作组公布的《中风病诊断和疗效评定标准》。 (1)符合上述脑卒中中西医诊断标准,并经CT 或 MRI 确诊者; (2)手功能障碍为脑卒中所致者; (3)神志清楚、生命体征平稳者; (4)年龄 35~70岁者; (5)首次中风,且病程为<=6个月; (6)对本研究具有良好的依从性者,且签署知情同意书。 3.中风后手痉挛诊断标准参照《脑卒中康复治疗技术 ·脑血管病的康复评定》,临床表现为患手肌张力异常增高,肌协调功能异常,改良的Ashworth 痉挛评级>0级。

Inclusion criteria

1.The diagnostic criteria of western medicine refer to the diagnostic criteria of "Stroke" in the 2010 "Guidelines for Prevention and Treatment of Cerebrovascular Diseases in China", and all are diagnosed as cerebrovascular disease through CT or MRI; 2.The diagnostic criteria of TCM refer to the "Criteria for Diagnosis and Efficacy Evaluation of Stroke" published by the Encephalopathy Emergency Cooperation Group of the State Administration of Traditional Chinese Medicine in January 1996. (1)Patients meet the above-mentioned diagnostic criteria of Chinese and Western medicine for stroke and are diagnosed by CT or MRI; (2)Hand dysfunction caused by stroke; (3)Patients with clear consciousness and stable vital signs; (4)Aged 35 to 70 years; (5)The first stroke, and the course of the disease is <=6 months; (6)Patients who have good compliance with this research and signed an informed consent form. 3.The diagnostic criteria for post-stroke hand spasm refer to "Stroke Rehabilitation Treatment Technology · Rehabilitation Evaluation of Cerebrovascular Diseases". The clinical manifestations are abnormally increased hand muscle tone, abnormal muscle coordination function, and modified Ashworth spasm rating >0.

排除标准:

1.合并有严重的心脑血管病、肝肾疾病等其他系统疾病者; 2.合并其他手腕及手指关节疾病者; 3.同时进行其他治疗且方法有效者; 4.脑卒中急性期或病情多次反复发作者; 5.精神病患者; 6.对冷热等温度觉无法感知的患者。

Exclusion criteria:

1.Patients with severe cardiovascular and cerebrovascular diseases, liver and kidney diseases and other system diseases; 2.Patients with other wrist and finger joint diseases; 3.Other treatments at the same time and the method is effective; 4.Patients with acute stroke or recurrent disease; 5.Mentally ill patients. 6.Patients who cannot perceive temperature such as cold and heat.

研究实施时间:

Study execute time:

From 2020-04-01

To      2023-04-30

征募观察对象时间:

Recruiting time:

From 2021-09-01

To      2022-04-01

干预措施:

Interventions:

组别:

对照组

样本量:

30

Group:

Control group

Sample size:

干预措施:

常规针刺治疗

干预措施代码:

Intervention:

Routine acupuncture treatment

Intervention code:

组别:

治疗组

样本量:

30

Group:

Treatment group

Sample size:

干预措施:

常规手功能训练基础上在上八邪穴上给予热敏灸疗法

干预措施代码:

Intervention:

On the basis of routine hand function training, give heat-sensitive moxibustion therapy on the Shangbaxie points

Intervention code:

样本总量 Total sample size : 60

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

河南

市(区县):

郑州

Country:

China

Province:

He'nan

City:

Zhengzhou

单位(医院):

河南中医药大学第一附属医院

单位级别:

三级甲等

Institution/hospital:

The First Affiliated Hospital of He'nan University of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

手部功能恢复情况

指标类型:

主要指标

Outcome:

Recovery of hand function

Type:

Primary indicator

测量时间点:

治疗前和治疗终点(治疗满 4 周)

测量方法:

肢体运动功能Fugel-Meyer评分

Measure time point of outcome:

Pre-treatment and treatment endpoint (after 4 weeks of treatment)

Measure method:

Fugel-meyer scale for motor function

指标中文名:

日常生活能力改善情况

指标类型:

主要指标

Outcome:

Improvement of daily living ability

Type:

Primary indicator

测量时间点:

治疗前和治疗终点(治疗满 4 周)

测量方法:

改良 Bathel 指数评分

Measure time point of outcome:

Pre-treatment and treatment endpoint (after 4 weeks of treatment)

Measure method:

Modified Bathel index scoring

指标中文名:

手部痉挛分级

指标类型:

主要指标

Outcome:

Hand spasm grading

Type:

Primary indicator

测量时间点:

治疗前和治疗终点(治疗满 4 周)

测量方法:

改良 Ashworth 肌张力分级

Measure time point of outcome:

Pre-treatment and treatment endpoint (after 4 weeks of treatment)

Measure method:

Modified Ashworth muscle tone grading

指标中文名:

手运动和感觉功能的评定

指标类型:

主要指标

Outcome:

Hand motion and sensory function assessment

Type:

Primary indicator

测量时间点:

治疗前和治疗终点(治疗满 4 周)

测量方法:

改良 Lindmark 评定

Measure time point of outcome:

Pre-treatment and treatment endpoint (after 4 weeks of treatment)

Measure method:

Improved Lindmark assessment

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它

说明

Fate of sample 

Others

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 35
Min age years
最大 70
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

具体方法将60例研究对象按照纳入本研究的顺序从1到60编号,从随机数字表任一行任一列开始,依次读取两位数作为一个随机数录于编号下,然后将得到的全部随机数从小到大进行编号(数据相同的按先后顺序编序号),规定序号1-30的研究对象为治疗组,序号31-60的研究对象为对照组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Methods 60 patients, the research object in the order included in this study, numbered from 1 to 60 from a random number table Ren Yixing Ren Yilie began, in turn read two digits as a random number recorded in number, and then will get all of the random number since the childhood are num

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

不适用。

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Not applicable.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

本研究采用病例记录表。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

In this study, Case Record Form (CRF) will be used.

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统